Acute migraine treatment with oral triptans and NSAIDs in a managed care population

Headache

Volumn 48, Issue 8, 2008, Pages 1176-1185

  Ng Mak, Daisy S ^a,b   Hu, X Henry ^a   Chen, Ya Ting ^a   Ma, Larry ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

^b Merck and Co ^*  (United States)

Author keywords

Acute migraine; Combination therapy; NSAIDs; Oral triptans; Treatment patterns; Treatment regimens

Indexed keywords

ACETYLSALICYLIC ACID; ACETYLSALICYLIC ACID PLUS BUTALBITAL PLUS CAFFEINE; ACTRON; ALMOTRIPTAN; ANACIN; BUTALBITAL; BUTALBITAL PLUS CAFFEINE PLUS PARACETAMOL; CELECOXIB; CINNAMEDRINE; DEXTROPROPOXYPHENE; DICLOFENAC; ELETRIPTAN; EXCEDRIN; FLURBIPROFEN; FROVATRIPTAN; HYDROCODONE; HYDROCODONE BITARTRATE PLUS PARACETAMOL; IBUPROFEN; INDOMETACIN; ISOMETHEPTENE MUCATE; KETOROLAC; MELOXICAM; NAPROXEN; NARATRIPTAN; NON PRESCRIPTION DRUG; NONSTEROID ANTIINFLAMMATORY AGENT; OXYCODONE; PARACETAMOL; RIZATRIPTAN; SUMATRIPTAN; TIZANIDINE; TRIPTAN DERIVATIVE; VALDECOXIB; ZOLMITRIPTAN;

ARTICLE; DEMOGRAPHY; DISEASE SEVERITY; DRUG EFFICACY; EMPLOYMENT; ETHNICITY; FOLLOW UP; FUNCTIONAL STATUS; HEALTH INSURANCE; HUMAN; MAJOR CLINICAL STUDY; MANAGED CARE; MIGRAINE; MONOTHERAPY; NAUSEA; PATIENT SATISFACTION; PRESCRIPTION; PRIORITY JOURNAL; STATISTICAL ANALYSIS;

ACUTE DISEASE; ADMINISTRATION, ORAL; ADULT; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CLINICAL TRIALS AS TOPIC; DATABASE MANAGEMENT SYSTEMS; DRUG THERAPY, COMBINATION; FEMALE; FOLLOW-UP STUDIES; HEALTH SURVEYS; HUMANS; MALE; MIDDLE AGED; MIGRAINE DISORDERS; NAUSEA; PATIENT SATISFACTION; PATIENT SELECTION; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES; SEVESO ACCIDENTAL RELEASE; TRYPTAMINES; UNITED STATES;

EID: 51249104854     PISSN: 00178748     EISSN: 15264610     Source Type: Journal    
DOI: 10.1111/j.1526-4610.2007.01055.x     Document Type: Article

References (11)

1. Lipton RB, Bigal ME, Goadsby PJ. Double-blind clinical trials of oral triptans vs other classes of acute migraine medication - a review. Cephalalgia. 2004 24 : 321 332.
2. Lipton RB, Scher AI, Kolodner K, Liberman J, Steiner TJ, Stewart WF. Migraine in the United States: Epidemiology and patterns of health care use. Neurology. 2002 58 : 885 894.
3. Krymchantowski AV. Naproxen sodium decreases migraine recurrence when administered with sumatriptan. Arq Neuropsiquiatr. 2000 58 : 428 430.
4. Krymchantowski AV, Barbosa JS. Rizatriptan combined with rofecoxib vs. rizatriptan for the acute treatment of migraine: An open lable pilot study. Cephalalgia. 2002 22 : 309 312.
5. Krymchantowski AV, Bigal ME. Rizatriptan versus rizatriptan plub rofecoxib versus rizatriptan plus tolfenamic acid in the acute treatment of migraine. BMC Neurology 2004 4 : 10 www document]. Available at: http://www.biomedcentral.com/1471-2377/4/10 (accessed 26 June 2007).
6. Smith TR, Sunshine A, Stark SR, Littlefield DE, Spruill SE, Alexander WJ. Sumatriptan and naproxen sodium for the acute treatment of migraine. Headache. 2005 45 : 983 991.
7. SAS Institute, Inc. SAS/STAT User's Guide, Version 8. Cary, NC : SAS Institute, Inc 1999.
8. Lober E. Fixed drug combinations for acute treatment of migraine. CNS Drugs. 2005 19 : 769 784.
9. Stöllberger C, Finsterer J. Nonsteroidal anti-inflammatory drugs in patients with cardio- or cerebrovascular disorders. Zeitschrift für Kardiologie. 2003 92 : 721 729.
10. Ng-Mak DS, Cady R, Chen YT, Ma L, Bell CF, Hu XH. Can migraineurs accurately identify their headaches as migraine" at attack onset? Headache. 2007 47 : 645 653.
11. Malik SN, Hopkins M, Young WB, Silberstein SD. Acute migraine treatment: Patterns of use and satisfaction in a clinical population. Headache. 2006 46 : 773 780.